Switching off DNA repair-how colorectal cancer evades targeted therapies through adaptive mutability

Fahrer, J

Fahrer, J (corresponding author), Tech Univ Kaiserslautern, Div Food Chem & Toxicol, Dept Chem, D-67663 Kaiserslautern, Germany.

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020; 5 (1):

Abstract

A very recent study by Russo et al. published in Science demonstrates that colorectal cancer (CRC) cells adapt to targeted therapies by downregulating......

Full Text Link